News & Updates

Adding ipatasertib to dual anti-HER2 maintenance therapy appears to be safe and beneficial to patients with HER2-positive metastatic breast cancer harbouring PIK3CA mutations, according to a phase Ib study.

Breast cancer survivors often experience female sexual dysfunction (FSD), which is significantly associated with disease-related factors and the lack of sexual counselling, reports a study.

A recent study has shown the effectiveness and precision of semi-solid extrusion (SSE) 3D printing in producing various formulations of ondansetron HCl dihydrate in hospital pharmacies.

Many patients with triple-negative breast cancer (TNBC) have a lower tolerated dose of capecitabine relative to the recommended adjuvant dose, a study has shown.

At an industry-sponsored symposium during the International Liver Cancer Association (ILCA) 2025 Annual Conference, Dr Krittiya Korphaisarn of Mahidol University, Bangkok, Thailand, reviewed systemic therapy for advanced hepatocellular carcinoma (HCC), focusing on lenvatinib as a second-line (2L) option following immunotherapy (IO). Professor Joseph Llovet of the University of Barcelona, Barcelona, Spain, and Tisch Cancer Institute at Mount Sinai, New York, US, and Professor Masatoshi Kudo of the Kindai University, Osaka, Japan, discussed the integration of systemic and locoregional treatments for intermediate HCC to optimize outcomes through multidisciplinary care.

A new genomic predictive model has identified mutated genes that are associated with the most aggressive anaplastic thyroid cancer (ATC), according to a study.

Ultraprocessed foods (UPFs) are associated with several preventable diseases and must be viewed not only through a nutritional lens but also as addictive, industrially engineered substances, which can be likened to cigarettes, suggests a recent study.

A 67-year-old man was diagnosed with polycythaemia vera (PV) in 2005. Over the next several years, he re­ceived various cytoreductive agents, including anagrelide, pegylated inter­feron (IFN) and hydroxyurea.